< 1 minute read
Nov. 26, 2021

Sivopixant: A P2X3 ligand-gated Ion Channel Antagonist

S-600918

purinergic receptor (ion channel) antagonist up to 300 mg PO QD, phase IIb, chronic cough from opt. of prior P2X3 antagonist Bioorganic and Medicinal Chemistry Letters Shionogi

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in